Dr. Nie is currently the head of Clinical Pharmacology & Pharmacometrics & Clinical Bioanalysis at Abbisko Therapeutics
First Co-chair of core working group of DIA China Clinical Pharmacology Community
Committee Member of Quantitative Pharmacology Committee of Chinese Pharmacology Society
Member of IFPMA Task force on ICH E11A EWG
Over 13 years industry working experiences, held various positions including head of CP group at ZaiLab, Clinpharm TA head of hematology/gene therapy at Janssen China R&D, Clinpharm at Novartis Oncology ClinPharm (China) and Senior Principle Scientist at Roche modeling and simulation group (US).
Participated in multiple draft CDE guidelines review and has multiple publications including white paper of value and its general considerations of quantitative pharmacology in China innovative drug development.
BS at Nanjing University, PhD at SUNY Buffalo, Joint lab of Prof.Almon and Prof Jusko.
现担任和誉生物医药临床药理负责人，从头搭建起公司临床药理部门，负责公司管线的临床药理，定量药理学和临床生物分析。中国药理学会定量药理专业委员会委员，第一任DIA临床药理社区核心工作组组长
博士毕业于美国纽约州立大学buffalo分校，国际著名药理学家Prof William Jusko 联合实验室。
罗氏美国全球定量药理部工作后回国，加入和誉之前，分别在再鼎担任临床药理负责人，强生担任中国临床药理部门血液肿瘤领域负责人
作为DIA 临床药理社区第一任核心工作组两位组长之一，组织参与推动临床药理社区的各种活动，如组织协调临床药理科学论坛、中日临床药理DIA 年会、策划DIA能力建设学院临床药理课程等。曾担任 ICH E11A EWG IFPMA 工作组成员
参与发表了多篇学术论文包括中国新药研发中定量药理学研究的价值及其一般考虑等白皮书的制定及多份CDE临床药理相关指南的起草审阅工作，参编《临床药代动力学与药效动力学研究：基础与前沿》。